Join to View Full Profile
2080 Century Park ESte 803Los Angeles, CA 90067
Phone+1 424-535-1874
Dr. Berz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Hematology and Medical Oncology, 2005 - 2008
Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 2002 - 2005
Humboldt University of Berlin - Charite Faculty of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2011 - 2025
LA State Medical License 2012 - 2015
RI State Medical License 2005 - 2007
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
- A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours Start of enrollment: 2018 Jul 05
Publications & Presentations
PubMed
- HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors WithAlterations: A Phase Ia Dose-Escalation Study.John V Heymach, Frans Opdam, Minal Barve, Hai-Yan Tu, Yi-Long Wu
Journal of Clinical Oncology. 2025-04-10 - Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumors.Kevin Harrington, Shigehisa Kitano, Valentina Gambardella, Eileen E Parkes, Irene Moreno
Future Oncology. 2025-01-01 - 14 citationsPreclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma.Vivek Subbiah, Sant P Chawla, Anthony P Conley, Breelyn A Wilky, Anthony Tolcher
Clinical Cancer Research. 2023-08-15
Press Mentions
Biocept to Present Study Results from Target Selector™ Testing in the Cerebrospinal Fluid of Patients with Lung Cancer at the IASLC Liquid Biopsy MeetingOctober 1st, 2020
G1 Therapeutics to Present New Clinical Data Across Pipeline at European Society for Medical Oncology (ESMO) 2019 CongressSeptember 10th, 2019
Kadmon Presents Encouraging Data on Tesevatinib in EGFR-Mutated Non-Small Cell Lung Cancer with Brain Metastases and/or Leptomeningeal MetastasesDecember 6th, 2016- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
